MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ARGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

argenx SE (ARGX) Ownership - Who owns argenx SE?

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
2373
Web
https://www.argenx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
56.41B
P/E Ratio
39.69
Total Cash
3.93B
Projected Growth
1.49
Total Debt
43.15M
Revenue
4.66B
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash/Share
63.17
Total Debt/Equity
N/A
Revenue/Share
70.41 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ARGX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ARGX
A.I. Advisor
published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
2373
Web
https://www.argenx.com